01/06/2023 francesoir.fr  10min 🇬🇧 #229291

 Énième déformation médiatique des propos du Pr Raoult, à propos de l'efficacité du vaccin anti-Covid: le point avec le Pr Parola de l'Ihu-Méditerranée

International support to Professor Raoult and the Ihu Méditerranée team



F. Froger / Z9, pour France-Soir; Pixabay

Professor Raoult of IHU Méditerannée in Marseille, France received today a mark of support from world-class scientists and doctors in a letter initiated by non-profit organization BonSens.org. This was sparkled by an article published in Le Monde by a group of french doctors in opposition to the recent publication of Professor Raoult and his team regarding the positive effect of early treatment with hydroxychloroquine on 30 423 patients. The opponents called it a « wild clinical trial » when IHU mediterrannée was caring and treating patients. This letter has already collected more than 50 signatures from doctors and scientists from various countries (France, United Kingdom, South Africa, Brazil, United States,...).

A mark of solidarity from the international scientific community has emerged in the last 24 hours in response to the constant attacks suffered by the former director of the IHU Méditerranée and his researchers. We were able to consult the messages of support sent by the various scientists and doctors who mobilized quickly to provide support not only to Professor Raoult but also to the other researchers and professors of the IHU who are targeted and attacked in the paper published in Le Monde.

The  letter of support is reproduced below, BonSens.org association initially solicited doctors or scientists in the field of Health or biology but were soon joined by other influential individuals for diverse fields of expertise.

Early management of Covid-19 patients has saved lives

We, the signatories of this letter, on the basis of our experience of Covid-19 in hospital, our practice in general practice and/or our reading of several hundred peer-reviewed scientific publications on the subject, confirm that early management of patients with Covid-19 has saved lives.

No, there are no unregulated clinical studies at the IHU Marseille

We assert that retrospective studies gathering hospital data from patients treated within an establishment do not constitute « uncontrolled clinical trials ». They are observational studies based on the act of care, and their scientific quality is no less than that of randomized trials, which are generally controlled by the pharmaceutical industry. It is important for the advancement of medical science that this type of study be published in scientific journals and that the data be made available to the scientific community.

We support the early care approach proposed at the IHU Marseille

We therefore support the early treatment approach adopted in March 2020 by the Marseille IHU under the direction of Professor Didier Raoult, and we support his initiative to publish the results of these early treatments for the scientific community and for the quality of public debate.

Professor Raoult is not isolated

We affirm that Professor Raoult is not isolated in the medical and scientific world, and that in many countries such as India, most of Africa and many Brazilian states, early care has been used successfully.

Hydroxychloroquine and ivermectin are of undeniable interest in Covid19

We maintain that several hundred peer-reviewed studies report an undeniable significant advantage for treatments based on hydroxychloroquine and/or ivermectin, with or without azithromycin or doxycycline, in the early management of Covid19 disease. It should be remembered that Professor Raoult stated very early on that hydroxychloroquine alone was only relatively effective, and that he believed that only the combination with azithromycin was truly effective.

Hydroxychloroquine in current doses is not dangerous

We would remind you that the safe use of hydroxychloroquine and ivermectin, with or without azithromycin, is well known to hospital and city doctors, and that when these drugs have been used in standard doses over a short period as early treatment, no serious study has been able to prove any additional risk to patients. At a time when the health authorities were only recommending Doliprane® and confining patients to their homes, early treatment with drugs that are very well known to doctors has saved lives.

Doctors can prescribe outside the AMM

Finally, we remind you that neither hydroxychloroquine nor ivermectin have ever been banned from prescription in hospitals, and that in general practice, the ban on prescribing hydroxychloroquine was only effective between March 25, 2020 and July 10, 2020.

This freedom to prescribe has since been confirmed by the ANSM (French Drug Agency) and Professor Salomon, Director General of Health, who have declared that doctors can prescribe this molecule off-label.

According to the Académie de Médecine and the Ordre des Médecins, 20% of prescriptions in France are « off-label », and this figure can rise to 80% in certain specialties. Why should what is widely authorized and used by all doctors not be so for Professor Raoult?

Randomized trials halted early despite efficacy signals

We also recall that when the fraudulent Lancet study was published, Mr. Véran, then Minister of Health, suspended patient enrolment in the hydroxychloroquine arms of the ongoing randomized Discovery and Hycovid trials. When the fraud was revealed, and the Lancet publication retracted, these enrolments were nevertheless not resumed, even though it was clear that there was already a signal of efficacy of the molecule that could possibly have been confirmed by a larger cohort.

We ask that the signatories of the tribune against Prof. Raoult specify their conflicts of interest

We therefore disagree on this issue with the article by around twenty scientists  published in the newspaper Le Monde on 28 May 2023, and call for their conflicts of interest to be disclosed to the general public in order to enlighten citizens about the reasons for their positions.

Independent Commission of Inquiry

Finally, we support Professor Raoult's call for an independent commission of enquiry with international experts to be set up to assess the performance of early therapies such as those prescribed at the IHU, and used in many countries.

Non-profit BonSens.org includes many scientists as founders: Professor Perronne, world-renowned infectiologist, Dr. Gérard Guillaume, Jean-François Lesgards doctor in biochemistry, Corinne Reverbel doctor in microbiology and Xavier Azalbert director of France-Soir are among the co-founders. BonSens.org has worked tirelessly since 2020 to restore common sense on human, societal and economic health topics through scientific publications in peer-reviewed journals and legal actions. More than 60 legal actions have been taken on early treatment, in support of suspended caregivers, on the side effects of Covid19 vaccination, on vaccine contracts as well as on SMS exchanges between Albert Bourla president of Pfizer and Ursula Von der Leyen.

Signatories :

Doctors and scientists

Pr. Christian Perronne, MD, PhD, Infectiologist, France

Dr. Peter Mc Cullough, MD, MPH, Cardiologist, Epidemiologist, Texas

Katarina Lindley D.O. FACOFP, President Global Health Project, COO Global COVID Summit, President Texas AAPS

Dr. Gérard Guillaume, MD, Rhumatologist

Hélène Strohl-Maffesoli, Honorary General Inspector of Social Affairs (IGAS), Paris, France

Pr. Hector Carvallo, Prof. of Internal Medicine, Buenos Aires, Argentina

Pr. Roberto Hirsch, Prof. of Infectology, Buenos Aires, Argentina

Dr. Raphael Stricker, MD, Internal Medicine, Director of Union Square Medical Associates, San Francisco, CA, USA.

Dr. Sabine Hazan, Gastroenterologist, Researcher, Clinical Trial Expert, USA

Dr. Flavio A. Cadegiani, MD, MSc, PhD, Brasilia, Brazil

Dr. Mike Yeadon, Managing Director, Yeadon Consulting Ltd, Former Vice President & Global Head of Respiratory & Allergic Diseases Research

Pr. Patrick Forterre, Microbiologist, Universitaire, membre de l'Académie Européenne de Microbiologie

Jennifer Jones, B.S. Chemistry, J.D Law, Chemist, Intellectual Property Attorney (retired), Camas, WA

Dr Louis Fouché, MD, Resuscitator, Marseille,France

Dr Eivind Vinjevoll, MD, Senior consultant anaesthesiologist, Volda, Norway

Dr. Simone Gold, MD, JD, Founder, AFLDS, CEO, GoldCare, USA

Dr. Eric Menat, MD, Muret, France

Jean-François Lesgards, PhD, Biochemist reseacher, Oxydative stress Inflammation. Université Aix Marseille, France

Dr. Gérard Delépine, Surgical Oncologist, without conflicts of interest, France

Dr. Nicole Delépine, Pediatrician, Oncologist without conflicts of interest, France

Dr. Klaus Schustereder, General Internist, Suisse

Dr. Marsha Y. Blakeslee, D.O, Severna Park, MD, Internal Medicine, USA

Dr. Gayln Perry, MD, Perry Center for Pediatric and Adult Sleep Care, CEO and Owner, Kansas City

Dr. Jean Emsallem, Vascular Doctor (Angeliologist), Lecturer at the Faculty of Medicine, Sorbonne University of Paris and the Faculty of Medicine of Marseille, France

Dr. Jose Iglesias, DO FASN, Associate Professor of Medicine, Hackensack Meridian University School of Medicine, Jersey Shore University Hospital, USA

Dr. Gérard Maudrux, Former President of the Health Insurance Fund for the Liberal Professions, Former President of the Pension Fund for Doctors of France, Member of the Academy of Surgery, France

Dr. Claude Escarguel, Hospital microbiologist and former president of the national union of practitioners of general hospitals, Spokesperson of the collective of doctors « AZI-THRO- Hospitalizations » and co-president of the association of covid-long patients (UPGCS), member of the scientific council of the Luc Montagnier Foundation

Dr. Tess Lawrie, Director of EbMCsquared CiC

Dr Edmund Fordham, PhD, FInstP

Hélène Banoun, Pharmacist biologist, PhD, former INSERM researcher

Dr. Marc Rendell, M.D., physician, Newport Coast, California

Dr. Eleftherios Gkioulekas, Professor of Mathematics, Undergraduate Program Coordinator, School of Mathematical and Statistical Sciences, University of Texas Rio Grande Valley

Dr. Gerilyn E. Cross, M.D., F.A.C.O.G., Obstetrician/Gynecologist, Hormone Therapy of Citrus County, Crystal River, FL, U.S.A.

Dr. Eric Loridan, General and digestive surgeon, Boulogne sur mer

Dr. Timothy Stonesifer, DO, Chambersburg, USA

Dr. Carrie Cannon, MD, MS

Dr. Hélène Chollet, General practitioner, volunteer at IHU at HDJ COVID

Dr. Daniel Chollet, Respirologist

Dr. Françoise Giorgetti, ENT doctor, volunteer doctor at IHU Marseille

Dr. Nicolas Zeller, General practitioner

Dr Corinne Navarro, General practitioner

Dr. Alain Joseph, Specialist in general medicine, active retiree

Dr Marc Arer, Retired physician

Dr Jean Valette, specialist in General Medicine, retired

Dr Martine Fleury, Retired psychiatrist

Dr Jean-Marc Rehby, General practitioner

Rachel Maldonado, MSW, LSW, Therapist & Life Coach, Chicago, Illinois

Corinne Reverbel, PhD Biochemistry

Bernard Sudan, former Head of Pharmacology and Toxicology Laboratory at Ciba-Geigy, Ciba, Novartis Basel, Switzerland

Dr Lucy Kerr,MD, Director SonImage, Brésil

Dr. Claudia Chaufan, MD, PhD Canadian COVID Care Alliance (CCCA), Canada

Dr. Timothy Stonesifer, MD, PA, USA

Dr. Claudia Chaufan, MD, PhD Canadian COVID Care Alliance (CCCA), Canada

Dr. Timothy Stonesifer, MD, PA, USA

Personalities in support

Michel Maffesoli, Professor Emeritus at the Sorbonne

Laurent Mucchielli, CNRS Research Director, France

Alain Houpert, Senator, France

Laurence Muller-Bronn, Senator, France

Sylvie Goy Chavent, Senator, France

René CHICHE, Professor of Philosophy, National Vice-President Action & Democracy, Member of the Conseil supérieur de l'éducation

Mary Beth Pfeiffer, Investigative Journalist, Author: « Lyme: The First Epidemic of Climate Change »

Paul Medhurst, PhD, NPP, Retired U.N. Officer, Prof., Police, Army, Penzance, U.K.

Xavier Azalbert, Investigative & Scientific journalist, Mathematician & Economist, France

Carole H. Browner, Distinguished Research Professor, department of Anthropology, department of Gender Studies, Center for Culture and Health, Semel Institute for Neuroscience and Human Behavior University of California, Los Angeles